Veterinary Medicines

NOBILIS MA5+CLONE 30 LIOFILIZADO PARA SUSPENSION OCULONASAL Y PARA ADMINISTRACION EN AGUA DE BEBIDA PARA POLLOS

Authorised
  • Newcastle disease virus, strain Clone 30, Live
  • Avian infectious bronchitis virus, type Massachusetts, strain Ma5, Live
Download as PDF

Product identification

Medicine name:
NOBILIS MA5+CLONE 30 LIOFILIZADO PARA SUSPENSION OCULONASAL Y PARA ADMINISTRACION EN AGUA DE BEBIDA PARA POLLOS
Active substance:
  • Newcastle disease virus, strain Clone 30, Live
  • Avian infectious bronchitis virus, type Massachusetts, strain Ma5, Live
Target species:
  • Chicken
Route of administration:
  • Nebulisation use
  • In drinking water use
  • Oculonasal use

Product details

Active substance and strength:
  • Newcastle disease virus, strain Clone 30, Live
    10.00
    50% Embryo Infective Dose
    /
    1.00
    Dose
  • Avian infectious bronchitis virus, type Massachusetts, strain Ma5, Live
    10.00
    50% Embryo Infective Dose
    /
    1.00
    Dose
Pharmaceutical form:
  • Lyophilisate for oculonasal suspension/use in drinking water
Withdrawal period by route of administration:
  • Nebulisation use
    • Chicken
      • Meat and offal
        0
        day
      • Egg
        0
        day
  • In drinking water use
    • Chicken
      • Meat and offal
        0
        day
      • Egg
        0
        day
  • Oculonasal use
    • Chicken
      • Meat and offal
        0
        day
      • Egg
        0
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI01AD11
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Spain
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Full application - Known active substance (Article 12(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Merck Sharp & Dohme Animal Health S.L.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Intervet International B.V.
Responsible authority:
  • Spanish Agency Of Medicines And Medical Devices
Authorisation number:
  • 2906 ESP
Date of authorisation status change:

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
Spanish (PDF)
Published on: 5/03/2025
Download

Package Leaflet

This document does not exist in this language (English). You can find it in another language below.
Spanish (PDF)
Published on: 5/03/2025
Download

Labelling

This document does not exist in this language (English). You can find it in another language below.
Spanish (PDF)
Published on: 5/03/2025
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."